
Affimed NV is a biotechnology business based in the US. Affimed shares (AFMD) are listed on the NASDAQ and all prices are listed in US Dollars. Affimed employs 197 staff and has a trailing 12-month revenue of around 0.00.
How to buy shares in Affimed
- Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – AFMD – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
Our top pick for
Beginners

Our top pick for
Building a portfolio

Our top pick for
Advanced traders

Affimed stock price (NASDAQ: AFMD)
Use our graph to track the performance of AFMD stocks over time.Affimed shares at a glance
Latest market close | $2.77 |
---|---|
52-week range | $2.23 - $8.64 |
50-day moving average | $3.28 |
200-day moving average | $4.84 |
Wall St. target price | $11.84 |
PE ratio | N/A |
Dividend yield | $0 (0%) |
Earnings per share (TTM) | $-0.66 |
Buy Affimed shares from these brokerages
Compare special offers, low fees and a wide range of types of investments among top trading platforms.*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
Is it a good time to buy Affimed stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Affimed price performance over time
Historical closes compared with the close of $2.77 from 2022-06-30
1 week (2022-06-23) | -2.46% |
---|---|
1 month (2022-06-01) | -11.50% |
3 months (2022-04-01) | -40.94% |
6 months (2021-12-31) | -49.82% |
1 year (2021-07-01) | -63.12% |
---|---|
2 years (2020-07-01) | -41.44% |
3 years (2019-07-01) | 2.97 |
5 years (2017-06-30) | 35.12% |
Affimed financials
Revenue TTM | $38.3 million |
---|---|
Gross profit TTM | $41.8 million |
Return on assets TTM | -20.74% |
Return on equity TTM | -52.82% |
Profit margin | -197.47% |
Book value | $0.95 |
Market capitalisation | $404.7 million |
TTM: trailing 12 months
Affimed share dividends
We're not expecting Affimed to pay a dividend over the next 12 months.
Affimed share price volatility
Over the last 12 months, Affimed's shares have ranged in value from as little as $2.23 up to $8.64. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Affimed's is 2.4891. This would suggest that Affimed's shares are significantly more volatile than the average for this exchange and represent a higher risk.
Affimed overview
Affimed N. V. , a clinical-stage biopharmaceutical company, focuses on discovering and developing cancer immunotherapies in the United States, Germany, and rest of Europe. Its lead product candidate is AFM13, which has completed Phase II clinical study for peripheral T-cell lymphoma; in Phase IIa clinical trial for CD30-positive lymphoma; and in Phase I clinical trial for hodgkin lymphoma. The company is also developing AFM24, a tetravalent, bispecific epidermal growth factor receptor, and CD16A-binding innate cell engager, which is in Phase IIa clinical trial for the treatment of advanced cancers; AFM28, an innate cell engager (ICE), which is in preclinical development to treat acute myeloid leukemia; and AFM32, an ICE candidate that is in preclinical development for the treatment of solid tumors. Affimed N. V.
Affimed in the news
Affimed Establishes Scientific Advisory Board
Affimed Establishes Scientific Advisory Board
Affimed Presents Preclinical Data of Novel Innate Cell Engager AFM28 at the Annual Meeting of the European Hematology Association (EHA)
Frequently asked questions
What percentage of Affimed is owned by insiders or institutions?Currently 3.403% of Affimed shares are held by insiders and 60.441% by institutions. How many people work for Affimed?
Latest data suggests 197 work at Affimed. When does the fiscal year end for Affimed?
Affimed's fiscal year ends in December. Where is Affimed based?
Affimed's address is: Technologiepark, Heidelberg, Germany, 69120 What is Affimed's ISIN number?
Affimed's international securities identification number is: NL0010872420 What is Affimed's CUSIP number?
Affimed's Committee on Uniform Securities Identification Procedures number is: N01045108
More guides on Finder
-
How to buy Intchains Group (ICG) stock when it goes public
Everything we know about the Intchains Group IPO, plus information on how to buy in.
-
How to buy Biostage (BSTG) stock when it goes public
Everything we know about the Biostage IPO, plus information on how to buy in.
-
How to buy Wang & Lee Group (WLGS) stock when it goes public
Everything we know about the Wang & Lee Group IPO, plus information on how to buy in.
-
How to buy OptMed (OMED) stock when it goes public
Everything we know about the OptMed IPO, plus information on how to buy in.
-
How to buy Lichen China (LICN) stock when it goes public
Everything we know about the Lichen China IPO, plus information on how to buy in.
-
How to buy LeeWay Services stock when it goes public
Everything we know about the LeeWay Services IPO, plus information on how to buy in.
-
How to buy Nano Labs (NA) stock when it goes public
Everything we know about the Nano Labs IPO, plus information on how to buy in.
-
How to buy Warrantee (WRNT) stock when it goes public
Everything we know about the Warrantee IPO, plus information on how to buy in.
-
How to buy Treasure Global (TGL) stock when it goes public
Everything we know about the Treasure Global IPO, plus information on how to buy in.
-
How to buy BIOLIFE4D (SAVU) stock when it goes public
Everything we know about the BIOLIFE4D IPO, plus information on how to buy in.
Ask an Expert